Open AccessEarly use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
Author(s) -
Massimo Filippi,
Maria Pia Amato,
Diego Centonze,
Paolo Gallo,
Claudio Gasperini,
Matilde Inglese,
Francesco Patti,
Carlo Pozzilli,
Paolo Preziosa,
María Trojano
Publication year - 2022
Publication title -
journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.541
H-Index - 136
eISSN - 1432-1459
pISSN - 0340-5354
DOI - 10.1007/s00415-022-11193-w
Subject(s) - medicine , multiple sclerosis , neurology , disease , neurodegeneration , neuroradiology , neuroinflammation , intensive care medicine , pediatrics , oncology , psychiatry